ERJ Podcast March 2026: Mortality in Severe Asthma

26 Mar 20264 min read0 viewsJournal Feed

GIST

Extract As part of the March issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Susanne Hansen (Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, and Centre for Clinical Research and Prevention, Frederiksberg Hospital, Copenhagen, Denmark) about her article on mortality in severe asthma as revealed by results from the NORDSTAR cohort, published in this issue of the ERJ ( https://doi.org/10.1183/13993003.01289-2025 ).

Clinical Editorial

Summary

European Respiratory Journal published a clinical update in Critical Care on 26 Mar 2026.

The item focuses on ERJ Podcast March 2026: Mortality in severe asthma.

Review the original article for the full source wording and details.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Lan RespRelated by Conditionasthma

Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study

Critical Care • 02 Apr 2026

Lan RespRelated by Conditionasthma

Source

European Respiratory Journal

ERJ Podcast March 2026: Mortality in Severe Asthma

GIST

Clinical Editorial

Summary

Source Reference

Related by Condition/Drug

Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study

Rilzabrutinib and the evolving landscape of oral therapies for uncontrolled asthma

Comment on Revised ISHAM-ABPA Guidelines for Diagnosing and Treating ABPA/Mycoses

Mepolizumab for Refractory Chronic Cough in Eosinophilic Airway Disease (MUCOSA) Trial

Modern Technologies in Lower Respiratory Tract Infections in Children

How vitamin D in pregnancy could offer a head start for better cognitive health